NovellusDx collaborates with Primetech as an Exclusive Supplier in Japan

 NovellusDx collaborates with Primetech as an Exclusive Supplier in Japan

Cancer Genetics Announces Acquisition of NovellusDx to Expand its Oncology Platform

Shots:
  • NovellusDx will provide its functional genomics assay FACT (Functional Annotation for Cancer Treatment) to Primetech, for pre-clinical market with sales, marketing and research/technical support in Japan exclusively
  • FACT has capability to determine trial outcomes in patients, now this system will help in developing anti-cancer drugs and mechanism of action
  •  Japan is the first territory where NovellusDx will be marketing as agent agreement
Click here to read full press release/ article | Ref: Primetech | Image:  Business wire

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post